Search

WEDNESDAY, July 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-d…

FRIDAY, June 20, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment…

WEDNESDAY, June 18, 2025 (HealthDay News) -- On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited r…